Quantcast

Lawsuit says generic medications were contaminated with cancer-causing impurity

By Carrie Bradon | Jun 14, 2019

CAMDEN, N.J. (Legal Newsline) – Two manufacturers and a distributor of generic medications are alleged to have sold contaminated products.

Glenn Roddey, Helen Johnson, Alicia Degracia and William Kolacek, on behalf of themselves and all others similarly situated, filed a complaint on May 21 in the U.S. District Court for the District of New Jersey against Camber Pharmaceuticals Inc., Hetero USA Inc., and Legacy Pharmaceutical Packaging LLC alleging fraud, conversion, violation of the California Consumer Legal Remedies Act and other counts. 

The plaintiffs are individuals who purchased losartan-containing generic medications that were manufactured by Hetero and Camber and distributed by Legacy. The suit states the medication was used for the treatment of high blood pressure, diabetic kidney disease, congestive heart failure and other issues.

The plaintiffs allege the medications were contaminated with a carcinogenic and liver-damaging impurity and that the medication was dangerous and worthless to the plaintiffs.

The plaintiffs are seeking a trial by jury; treble, statutory and punitive damages; interest; restitution of monetary relief; injunctive relief; attorneys' fees; expenses and costs of the suit; and other relief deemed fit. They are represented by Andrew J. Obergfel of Bursor & Fisher in New York City.

U.S. District Court for the District of New Jersey case number 1:19-CV-12763

Want to get notified whenever we write about U.S. District Court for the District of New Jersey Camden Division ?

Sign-up Next time we write about U.S. District Court for the District of New Jersey Camden Division, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

U.S. District Court for the District of New Jersey Camden Division

More News

The Record Network